In connection with the implementation of the project titled “Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under contract no. 2022/ABM/06/00005-00 for co-financing of a commercial project as part of the Competition for the development of targeted or personalized medicine based on acid-based medicinal products nucleic acid and small-molecule compounds. The Ordering Party conducts market research regarding the costs of purchasing reagents and diagnostic kits.
In order to submit an offer, please read the detailed content of the announcement placed in “supply” and send the completed offer form and the assortment and price form.